🇺🇸 FDA
Patent

US 6068844

Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof

expired A61KA61K38/1709

Quick answer

US patent 6068844 (Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/1709